Recent data suggest a negative effect of propofol anesthesia on cortisol secretion. The present study was designed to evaluate the effect of propofol anesthesia on the steroidogenic potential of the adrenal glands. The response of cortisol secretion to stimulation with an adrenocorticotropic hormone (ACTH) analog during intravenous anesthesia with propofol has not been reported before. The response of the secretion of cortisol, ll-deoxycortisol, and 17a-hydroxyprogesterone to tetracosactide stimulation was compared in patients anesthetized with propofol-nitrous oxide (n = 10) or thiopental-isoflurane-nitrous oxide (n = 10) and in normal volunteers (n = 10). The response to tetracosactide was similar in all three groups. An adequate increase in cortisol plasma concentration (more than 7.25 pg/dL) was obtained in all subjects except one volunteer. The increase in the plasma concentration of the cortisol precursors was also similar. We were unable to detect any influence of propofol anesthesia on the synthesis of cortisol in response to tetracosactide stimulation. (Anesth Analg 1995;80:573-6) T he opinion that clinically relevant concentrations of propofol have no significant effect on the production of cortisol by the adrenal glands has been challenged recently by the observations of O'Flaherty et al. ( 1). In a study in 45 unpremeditated patients undergoing laparoscopic tubal ligation, these authors observed a decrease in the plasma cortisol concentration during anesthesia with propofol in unstimulated patients. During surgical stimulation, cortisol concentrations returned to baseline levels. In contrast, in patients anesthetized with isoflurane and nitrous oxide, cortisol plasma concentrations did not change significantly in the absence of stimulation, but increased above baseline level (P < 0.001) during surgery. Since changes in adrenocorticotropic hormone (ACTH) were identical in both groups of patients, the authors concluded that propofol suppresses the secretion of cortisol by the adrenal glands. The purpose of the present study was to further investigate a possible effect of anesthetic concentrations of propofol on adrenal cortisol synthesis. Therefore, the response to stimulation of the secretion of cortisol and two of its precursors by the administration of tetracosactide This study was supported by a grant from Zeneca, Belgium.
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Anesthesia Research Society 0003-2999/95/$5.00 (SynacthenTM; Ciba-Geigy, Basel, Switzerland), a synthetic polypeptide with a similar structure to ACTH and identical activity, was compared in patients anesthetized with propofol or thiopental-isoflurane and in unstimulated volunteers.
Methods
The study protocol was approved by the Ethical Committee/Clinical Trials of the Faculty of Medicine of the Catholic University Leuven, and written informed consent was obtained from all study subjects. Twenty patients and 10 healthy volunteers participated in the study. All subjects were male, between 18 and 40 yr of age, and ASA physical status I. Patients received no chronic medications with the exception of nonsteroidal antiinflammatory drugs. To avoid possible diurnal variations in cortisol secretion, each study procedure started at 8:OO AM. The volunteers did not receive any medication, and were resting during the entire procedure. Twenty consenting patients scheduled for herniated disk repair or arthroscopic knee surgery were randomly allocated to one of two groups (n = 10). All patients received lorazepam, 1 mg orally, 60 min preoperatively, and fentanyl, 2 pg/kg intravenously, immediately before induction. In 10 patients anesthesia was induced with propofol, 1.75-2.5 mg/kg, and maintained with 66% nitrous oxide and propofol administered at a variable infusion rate Anesth Analg 1995;80:573-6 573 (90-200 pgkg-'smin-*).
In 10 other patients anesthesia was induced with thiopental, 4-6 mg/kg, and maintained with 66% nitrous oxide and isoflurane (0.5%-1.8% end-respiratory concentration). The administration of propofol and isoflurane was titrated to maintain blood pressure and heart rate within 20% of preoperative values. Tracheal intubation was facilitated with vecuronium, 0.1 mg/kg, and the patients were normoventilated. After a 45-min resting period in volunteers, or after 45 min of anesthesia during which period the patients were positioned and prepared for surgery, 0.25 mg of tetracosactide was administered intravenously. Venous blood samples were obtained before induction of anesthesia in patients, or after a 30-min resting period in volunteers, 45 min later (i.e., immediately before the administration of tetracosactide), and at 15,30,45, and 60 min thereafter. The plasma was separated and frozen for later determination of the concentration of cortisol by radioimmunoassay after dichloromethane extraction (2), 1 ldeoxycortisol (ll-deoxycortisol Double Antibody-iz51 RIA KitTM; ICN Biomedicals, Costa Mesa, CA), and 17a-hydroxyprogesterone by radioimmunoassay after cyclohexane-ethylacetate extraction (3). A satisfactory response to tetracosactide stimulation was defined as an increase in cortisol concentration of at least 7.25 pg/dL (200 nmol/L) within 60 min (4,5).
Results are expressed as mean values + SD. Wilcoxon's signed rank test was used to evaluate the changes in cortisol concentration over time within each group. The Kruskal-Wallis test was used to compare the differences in hormone concentration profiles between the three groups. The Fisher-Freeman-Halton test was applied to compare the number of subjects with a satisfactory response to tetracosactide stimulation. The null hypothesis was rejected when P < 0.05.
Results
The demographic data are summarized in Table 1 . There were no significant differences in age, weight, height, the number of patients scheduled for each type of surgery, or the number of patients receiving nonsteroidal antiinflammatory drugs preoperatively. The plasma concentrations of cortisol, 11 -deoxycortisol, and 17c~-hydroxyprogesterone are summarized in Table 2. No significant differences were observed between the three groups at any time, except for the basal cortisol concentration which was lower in volunteers (P = 0.015). Cortisol concentrations after 45 min of anesthesia or resting were significantly decreased compared to baseline values in each group (P < 0.01). The response of the plasma cortisol concentration to the injection of tetracosactide was similar in all three groups. Plasma cortisol increased by more than 7.25 pg/dL in all subjects except one volunteer (maximum increase 5.4 pg/dL).
Discussion
It has been demonstrated in vitro that propofol has a direct antisteroidogenic effect on cortical adrenal cells (6-B). However, concentrations of propofol similar to concentrations achieved during induction of anesthesia (5-10 pg/mL) would produce only a weak inhibition (~20%) of adrenal steroidogenesis in vitro (6-B). Plasma concentrations of propofol during maintenance of anesthesia for surface surgery are even lower (2-5 pg/mL) (9). With regard to the site of action of the antisteroidogenic effect, Robertson et al. (8) have demonstrated in vitro that propofol acted at the initial stages of the pathway, prior to the production of pregnenolone. The absence of accumulation of 17a-hydroxyprogesterone or 1 I-deoxycortisol in the present study indicates that propofol had no antisteroidogenic effect further in the cortisol synthesis pathway, i.e., blockade of the 21-hydroxylase or 11/3-hydroxylase enzyme, respectively. Due to differences in the degree of surgical stimulation, in the adequacy of the analgesic treatment, and in the depth of anesthesia, the interpretation of hormonal responses to anesthesia and surgery is cumbersome. Several investigators concluded that propofol, used for anesthesia (10-13) or sedation (5, 14, 15) , does not interfere with cortisol secretion. Occasionally observed decreases in the cortisol concentration were attributed to the effects of sedation or anesthesia on the stress response. In contrast, O'Flaherty et al. (1) concluded that propofol profoundly inhibits the cortisol response to stress, because of the observed decrease in cortisol concentration in spite of a significant increase in the ACTH concentration. The observation by Newman et al. (14) of a significant decrease in cortisol plasma levels in the presence of normal ACTH concentrations during sedation with propofol in intensive care patients may be interpreted as an argument in favor of this conclusion. However, similar to our observations, the response to tetracosactide was normal, and the authors concluded that propofol had no clinically significant effect on cortisol secretion. In the study by Fragen et al. (12) , cortisol and ACTH concentrations remained within the normal range after induction of anesthesia with propofol, while Fahmy et al. (16) observed an increase in both ACTH and cortisol concentrations during intravenous anesthesia with propofol. The observed changes in plasma cortisol concentration in our study patients were the result of the combined effects of the hormonal response to anesthesia and surgery and the response to tetracosactide. The present study does not exclude an influence of the anesthetic technique on the endogenous stimulation of cortisol synthesis:To identify the influence of anesthesia and surgery, we compared anesthetized patients with a group of unstimulated, unanesthetized volunteers. The lower baseline cortisol plasma concentration in volunteers (P = 0.015) was probably the result of the patients' apprehension, despite the use of sedative premeditation. During the first 45 min of anesthesia, the cortisol plasma concentrations decreased to the same level as in resting volunteers, indicating that anesthesia adequately blocked the cortisol response to the inflicted level of stress during the positioning of the patient and the preparation of the surgical field. Under these circumstances, the administration of tetracosactide implemented a similar stimulation of the adrenal cortex in the three study groups, resulting in a similar response. Demonstration of a normal response of the cortisol production to an exogenous ACTH analog indicates that corticosteroid synthesis by the adrenal cortex was not inhibited by the anesthetic technique (4). However, it does not exclude that the cortisol synthesis in response to lesser degrees of stimulation, e.g., a stress-induced increase in ACTH, is attenuated, as the study by O'Flaherty et al. (1) appears to indicate. Nevertheless, the absence of any accumulation of the cortisol precursors excludes blockade of the 21-hydroxylase or lip-hydroxylase enzyme as a cause of such attenuated response.
Other investigators have demonstrated that the response of cortisol synthesis to an exogenous ACTH challenge was normal after the administration of an induction bolus of propofol(12), after anesthesia with a propofol infusion (161, and during or after sedation with propofol infusions (5, 14, 15) . The present investigation demonstrated that the response to tetracosactide was also normal during maintenance of anesthesia with propofol, and, moreover, similar to the response in normal volunteers. In contrast, in the study by Fragen et al. (12) , the response to exogenous ACTH stimulation was completely absent after anesthesia in 10 patients who had received etomidate for induction. A blunted response to exogenous ACTH was also demonstrated by Crozier et al. (17) in 11
